-
Learn more about the awardees and their research
Introducing the 2024 Office of Autoimmune Disease Research R56 Awardees
The 2024 Office of Autoimmune Disease Research R56 awards will support short-term, highly meritorious extramural research focused on autoimmune disease topics highly impactful to quality of life and survival.
-
Explore the funding opportunities
Non-Communicable Diseases Funding Opportunities
ORWH is supporting research on non-communicable diseases in low- and middle-income countries and among Native American populations in the United States.
-
Read the announcement
ORWH Director Elected to the National Academy of Medicine
The National Academy of Medicine (NAM) has announced that ORWH Director, Janine Austin Clayton, M.D., FARVO, has been elected as a new NAM member.
-
Register for the event
Upcoming NIH Behavioral and Social Sciences Research Festival
The “NIH Behavioral and Social Sciences Research Festival” will take place November 6 – 7, 2024, and feature a keynote panel on the ORWH-sponsored Social Science & Medicine supplement about gender, power, and health.
-
Read more about the event
ORWH Leadership Advocate for Women’s Health Innovation
ORWH Deputy Director Vivan Ota Wang, Ph.D., and ORWH Health Science Policy Analyst Annina Burns, Ph.D., RD, were featured panelists at the 2024 Women’s Health Innovation Summit.
-
Learn more about PACHE’s pilot projects
Partnerships to Advance Cancer Health Equity (PACHE) Program Receives Funding
NIH has awarded additional funding to research teams supporting the National Cancer Institute’s PACHE program to develop more precise cancer prevention, detection, and treatment tools.
-
Learn more
ORWH Publishes New Funding Opportunity on the Health of Women of U3 Populations
The notice of special interest will support research that investigates inequities in women’s health.
-
Learn more
ORWH Participates in ODP Funding Opportunity to Support Expansion of Cancer Screenings in Populations that Experience Health Disparities
This funding opportunity seeks to support research to address barriers that impede the use of cancer screening and preventive services in populations that experience health disparities.
-
Explore the program
Sex and Gender Considerations in Health Care with a Focus on the Female Brain
ORWH Director, Janine Austin Clayton, M.D., FARVO, is featured in a new continuing medical education program on sex and gender considerations for neurological and psychiatric conditions.
-
Begin reading
Promoting Health Equity in Kidney Disease Clinical Studies
A new article by ORWH Health Science Policy Analyst Raven Hardy Richard, Ph.D., leverages a socioecological model framework to enhance clinical study participation diversity for apolipoprotein L1 (APOL-1)-mediated kidney disease.
About ORWH
Established in 1990, the Office of Research on Women's Health serves as the focal point for women's health research at the National Institutes of Health. For over thirty years, ORWH has worked across the NIH and beyond to advance our understanding of sex and gender as influences in health and disease, support women in biomedical careers, and stimulate research to improve the health of women.
Director's Corner
Image
Janine Austin Clayton, M.D., FARVO
Janine Austin Clayton, M.D., FARVO, was appointed Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health (NIH) in 2012. Dr. Clayton has strengthened NIH support for research on diseases, disorders, and conditions that affect women. She is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum, including research designs, analyses, and reporting in vertebrate animal and human studies. The policy serves as the keystone of NIH's initiative to enhance research reproducibility, rigor, and transparency.